Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, will present three abstracts highlighting significant advancements in the development of a ...

Analyst Mark Massaro of BTIG reiterated a Buy rating on Guardant Health (GH – Research Report), retaining the price target of $50.00.

With more than 10 miles of Bay shoreline, a Redwood City Council study session focused on its vulnerability to sea-level rise ...

Morgan Stanley analyst Tejas Savant maintained a Buy rating on Guardant Health (GH – Research Report) today and set a price target of ...

Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Exact Sciences (NASDAQ:EXAS) in the last three months. The following table summarizes their ...

--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the company will present modeling data evaluating the simulated ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the company will present modeling data evaluating the simulated benefit and burden ...

No teams are on bye this week. Before you make any Week 8 NFL picks, be sure to see the exact NFL score predictions from SportsLine expert Eric Cohen. Cohen, a SportsLine NFL expert and host of ...

Is Deepavali on October 31 or November 1? Well, we are here to clear your confusion and assist you in knowing the exact date and puja timings of Diwali. This year, Diwali will be celebrated on ...

Here’s how it works. Eli Iserbyt (Pauwels Sauzen-Bingoal) won the Exact Cross Heerderstrand in the Netherlands on his return to racing after his three-race ban for stamping, putting his anger ...

Wells Fargo has recently initiated Exact Sciences Corp (EXAS) stock to Overweight rating, as announced on August 28, 2024, according to Finviz. Earlier, on June 27, 2024, Scotiabank had initiated the ...